white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Weight-loss drug makers announce pricing
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Weight-loss drug makers announce pricing](https://www.aljazeera.com/wp-content/uploads/2025/11/2025-11-06T185129Z_914660707_RC25RHA5ELBD_RTRMADP_3_USA-TRUMP-1762456734.jpg?resize=1920%2C1080)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Weight-loss drug makers announce pricing](https://endpoints.news/wp-content/uploads/2025/10/GettyImages-2241031598.jpg)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Weight-loss drug makers announce pricing](https://i.abcnewsfe.com/a/95eafab5-efb8-4cc2-98f2-822ab18bd851/wegovy-zepbound-ap-jef-251106_1762445903979_hpMain_16x9.jpg?w=992)
























